Suppr超能文献

一名患有晚期肺动脉高压和混合性结缔组织病的患者接受免疫抑制治疗后的十年生存率。

Ten year survival of a patient with advanced pulmonary hypertension and mixed connective tissue disease treated with immunosuppressive therapy.

作者信息

Dahl M, Chalmers A, Wade J, Calverley D, Munt B

机构信息

Department of Medicine, University of British Columbia, Vancouver, Canada.

出版信息

J Rheumatol. 1992 Nov;19(11):1807-9.

PMID:1491407
Abstract

Pulmonary hypertension is the most frequent cause of death in patients with mixed connective tissue disease. The pulmonary hypertension is progressive and difficult to treat effectively. These patients experience considerable morbidity secondary to diminished cardiac function. We describe a case in which sequential administration of cyclophosphamide and cyclosporine A favorably altered the clinical and hemodynamic course of this serious complication.

摘要

肺动脉高压是混合性结缔组织病患者最常见的死亡原因。肺动脉高压呈进行性发展且难以有效治疗。这些患者因心功能减退而出现相当程度的发病情况。我们描述了一例病例,其中序贯给予环磷酰胺和环孢素A有利地改变了这一严重并发症的临床和血流动力学进程。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验